Literature DB >> 23487044

Chemotherapy-related cardiotoxicity.

Saurabh Aggarwal1, Jasmine Kamboj, Rohit Arora.   

Abstract

Cardiovascular toxicity caused by cancer therapy is a challenging area which needs thorough evaluation and research. Numerous studies, meta-analyses and reviews have been published in the past discussing cardiotoxicity caused by chemotherapeutic agents. A brief review of the on-target and off-target cardiotoxicities caused by chemotherapeutic agents is presented here. Cardiotoxicities are broadly outlined in terms of left ventricular dysfunction, hypertension and thromboembolic events. The mechanisms leading to the cardiotoxicity profiles of various chemotherapeutic agents are discussed. The management of various cardiotoxicities of chemotherapeutic agents is also discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23487044     DOI: 10.1177/1753944712474332

Source DB:  PubMed          Journal:  Ther Adv Cardiovasc Dis        ISSN: 1753-9447


  3 in total

1.  PTHrP attenuates osteoblast cell death and apoptosis induced by a novel class of anti-cancer agents.

Authors:  Sahiti Chukkapalli; Edi Levi; Arun K Rishi; Nabanita S Datta
Journal:  Endocrine       Date:  2015-08-11       Impact factor: 3.633

Review 2.  PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity.

Authors:  Jothilingam Sivapackiam; Monica Sharma; Thomas H Schindler; Vijay Sharma
Journal:  Curr Cardiol Rep       Date:  2020-06-19       Impact factor: 2.931

3.  Chemotherapy-induced Cardiac18F-FDG Uptake in Patients with Lymphoma: An Early Metabolic Index of Cardiotoxicity?

Authors:  Mayara L C Dourado; Luca T Dompieri; Glauber M Leitão; Felipe A Mourato; Renata G G Santos; Paulo J Almeida Filho; Brivaldo Markman Filho; Marcelo D T Melo; Simone C S Brandão
Journal:  Arq Bras Cardiol       Date:  2022-05-02       Impact factor: 2.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.